Skip to navigation Skip to content

Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS


The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

Read more

Read more

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Share

Clinical trials help to determine if treatments are safe and effective. Studies are monitored to ensure that the rights and safety of all participants are protected. Make an informed decision before agreeing to participate. Read more in our Guide to Participating in Clinical Trials.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

  1. Clinical Trial: Ofatumumab

    12-week study for treatment of Relapsing MS, followed by a 4.5-year extension study. Qualifying participants will receive study medication and study related exams at no cost. Compensation will be provided for time and travel costs.  To qualify: Must be between 18-55 year...
  2. Clinical Trial: ADS-5102 (amantadine extended release [ER] capsules)

    The INROADS study is now enrolling volunteers to help test an investigational study drug for people with MS who have trouble walking. Researchers want to learn if the investigational medication may help improve walking and become a future treatment option. If you qualify and ...
  3. Clinical Trial: Biomarker-Guided Combination Therapies for MS

    In people with MS, brain and cerebrospinal fluid biomarkers indicate inflammation or disease. Researchers at the National Institutes Health (NIH) seek volunteers with MS to see if 4 therapies given alone or combined affect MS biomarkers. They want to see if a change in biomark...
  4. Clinical Trial: ReCOVER – Clemastine Fumarate in Optic Neuritis

    WE ARE ACTIVELY RECRUITING PEOPLE EXPERIENCING A SUSPECTED OR DIAGNOSED ACUTE OPTIC NEURITIS IN AN EYE NOT PREVIOUSLY AFFECTED AND HAS YET TO RECEIVE STEROID TREATMENT FOR.    ReCOVER aims to assess the effect of clemastine as a myelin repair agent and its potential for th...
  5. Clinical Trial: Linking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis

    This project studies the link between performance on sensitive computer-based measures of cognitive functioning (games that test reaction time) and findings on neuroimaging (brain scans with MRI and PET) for people who are new to receiving Tecfidera to manage their MS.  At the...
  6. Clinical Trial: Virtual Reality for MS

    Researchers are looking at the impact of virtual reality on walking for individuals with relapse and remitting Multiple Sclerosis. The intervention group will receive 18 sessions of Treadmill Training with Virtual Reality and the active control comparison will receive 18 tr...
  7. Clinical Trial: Virtual Reality to Improve Quality of Life

    Participants with MS and other neurological disorders will be recruited to complete sessions of virtual reality (VR) viewing and game playing. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the exte...
  8. Clinical Trials: Transcranial Direct Current Stimulation Studies

    Researchers at New York University are recruiting people with MS for three studies involving transcranial direct current stimulation (tDCS, which involves low electrical current delivered via electrodes). Clinical Trial: A Pilot Trial of Remotely-Supervised Transcranial Dire...
  9. Clinical Trial: Tracking Health in Multiple Sclerosis (TracMS)

    In Trac-MS researchers are interested in learning more about the relationship between everyday behaviors, thinking abilities, and brain health in people with relapsing-remitting multiple sclerosis and cognitive impairment, ages 30-59. Specifically, they are interested in exami...
  10. Clinical Trial: Ketamine for MS-related fatigue

    Potential participants will come in to Johns Hopkins University for one visit. After signing the informed consent form and assessment of eligibility, participants will be randomly assigned to receive ketamine (12 participants) or midazolam (6 participants). They will receive o...
  11.  |<  <  2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11  >  >| 

Share


Learn About Clinical Trials

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact Us

Contact Us
Newly Diagnosed
If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Start Here